Catherine C. Turkel
Chief Development Officer
Management
Novus Therapeutics, Inc
United States of America
Biography
Dr. Turkel served as Chief Development Officer for Otic Pharma from 2015 to 2017. Dr. Turkel has more than 30 years of combined clinical practice and drug development experience and is currently responsible for leading all preclinical, clinical, regulatory, quality and pharmaceutical development functions at Novus. Dr. Turkel has successfully led global development project teams resulting in multiple registrations of new drug treatments around the world. Prior to Otic Pharma, Dr. Turkel held several R&D leadership positions at Allergan, Inc., including Vice President of Clinical Development for Neurology, Urology, and Pain, Vice President of Global Medical Affairs, and other positions from 1998 to 2015. Prior to Allergan, Dr. Turkel served as Director of Drug Development, Regulatory Affairs and Data Management at Cypros Pharmaceuticals from 1995 to 1998. Dr. Turkel’s industry tenure also includes past positions at IVAC Corporation, California Clinical Trials, and Siemens Infusion Systems as well as many years as a hospital based critical care pharmacist.
Research Interest
clinical practice and drug development preclinical, clinical, regulatory, quality and pharmaceutical development
